Clicky

PDS Biotechnology Corporation(PDSB) News

Date Title
May 23 PDS Biotechnology Corporation (PDSB)’s Versamune HPV Surpasses Survival Benchmarks in Recurrent Head and Neck Cancer Trial
May 22 PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 16 PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting
Sep 16 PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024
Aug 1 PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic Head and Neck Cancer
Jul 31 PDS Biotech to Host Clinical Program Update Conference Call on August 1, 2024, at 8 a.m. Eastern Time
Jul 29 PDS Biotech to Participate at BTIG Virtual Biotechnology Conference
May 15 PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results
May 9 PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer
May 9 PDS Biotech to Participate in Upcoming May 2024 Investor Conferences
May 7 PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024
May 3 PDS Biotechnology Announces Details of Virtual KOL Event
May 2 PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
Apr 23 PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer
Mar 30 PDS Biotechnology Corporation's (NASDAQ:PDSB) market cap dropped US$1.5m last week; individual investors who hold 59% were hit as were institutions
Mar 28 PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript
Mar 28 Q4 2023 PDS Biotechnology Corp Earnings Call
Mar 27 PDS Biotechnology Corp (PDSB) Reports Full Year 2023 Financial Results and Clinical Strategy Update
Mar 27 PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
Mar 20 PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results